# reload+after+2024-01-22 16:45:24.488788
address1§5200 Illumina Way
city§San Diego
state§CA
zip§92122
country§United States
phone§858 202 4500
fax§858 202 4766
website§https://www.illumina.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
fullTimeEmployees§11500
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Joydeep  Goswami M.B.A., Ph.D.', 'age': 52, 'title': 'CFO, Chief Strategy & Corporate Development Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 787304, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Susan H. Tousi', 'age': 54, 'title': 'Chief Commercial Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 790204, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jacob  Thaysen Ph.D.', 'age': 48, 'title': 'CEO & Director', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Stephanie  Campos', 'title': 'President', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kevin Carl Pegels', 'age': 56, 'title': 'Chief of Global Operations', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Scott  Ericksen', 'age': 51, 'title': 'VP & Chief Accounting Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Steven  Barnard Ph.D.', 'title': 'Chief Technology Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Carissa L. Rollins', 'age': 53, 'title': 'Chief Information Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sallilyn  Schwartz', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Charles E. Dadswell Esq.', 'age': 64, 'title': 'Senior VP & General Counsel', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 1060726, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§8
compensationRisk§10
shareHolderRightsRisk§6
overallRisk§10
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.162
priceToSalesTrailing12Months§4.640588
currency§USD
dateShortInterest§1702598400
forwardEps§0.83
pegRatio§-30.78
exchange§NMS
quoteType§EQUITY
shortName§Illumina, Inc.
longName§Illumina, Inc.
firstTradeDateEpochUtc§964791000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§c76f8ba3-209c-315d-a776-1d132bd357c6
gmtOffSetMilliseconds§-18000000
targetHighPrice§258.0
targetLowPrice§50.0
targetMeanPrice§138.08
targetMedianPrice§126.0
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§22
quickRatio§1.108
grossMargins§0.65778
ebitdaMargins§0.071
trailingPegRatio§3.3592
